Dishman Carbogen Amcis Limited (DCAL.BO)
INR 274.5
(-3.18%)
INR 274.5
(-3.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.53 Billion INR | -414.93% |
| 2022 | -298 Million INR | -265.46% |
| 2021 | 180.1 Million INR | 110.91% |
| 2020 | -1.65 Billion INR | -204.18% |
| 2019 | 1.58 Billion INR | -24.64% |
| 2018 | 2.1 Billion INR | 36.07% |
| 2017 | 1.54 Billion INR | 6.28% |
| 2016 | 1.45 Billion INR | -15.01% |
| 2015 | 1.71 Billion INR | 42.82% |
| 2014 | 1.19 Billion INR | 9.64% |
| 2013 | 1.09 Billion INR | 8.95% |
| 2012 | 1 Billion INR | 76.7% |
| 2011 | 567.58 Million INR | -29.06% |
| 2010 | 800.12 Million INR | -31.95% |
| 2009 | 1.17 Billion INR | -19.57% |
| 2008 | 1.46 Billion INR | 22.12% |
| 2007 | 1.19 Billion INR | 30.53% |
| 2006 | 917.08 Million INR | 80.37% |
| 2005 | 508.44 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -775.7 Million INR | -10.94% |
| 2023 Q4 | -699.2 Million INR | -17.26% |
| 2023 Q3 | -596.3 Million INR | -45.79% |
| 2023 FY | -1.53 Billion INR | -414.93% |
| 2023 Q1 | 170 Million INR | 124.04% |
| 2023 Q2 | -409 Million INR | -340.59% |
| 2022 Q2 | -100.5 Million INR | -350.62% |
| 2022 Q1 | 40.1 Million INR | 109.0% |
| 2022 FY | -298 Million INR | -265.46% |
| 2022 Q4 | -707.2 Million INR | -250.6% |
| 2022 Q3 | 469.6 Million INR | 567.26% |
| 2021 Q1 | 160.2 Million INR | 111.86% |
| 2021 Q2 | 111.9 Million INR | -30.15% |
| 2021 Q3 | 353.8 Million INR | 216.18% |
| 2021 Q4 | -445.8 Million INR | -226.0% |
| 2021 FY | 180.1 Million INR | 110.91% |
| 2020 Q2 | 73.8 Million INR | 134.44% |
| 2020 Q3 | -160.7 Million INR | -317.75% |
| 2020 Q4 | -1.35 Billion INR | -740.32% |
| 2020 Q1 | -214.3 Million INR | -129.77% |
| 2020 FY | -1.65 Billion INR | -204.18% |
| 2019 Q3 | 328.5 Million INR | -20.19% |
| 2019 Q1 | 343.1 Million INR | -54.46% |
| 2019 FY | 1.58 Billion INR | -24.64% |
| 2019 Q2 | 411.6 Million INR | 19.97% |
| 2019 Q4 | 719.8 Million INR | 119.12% |
| 2018 Q3 | 513.7 Million INR | 16.72% |
| 2018 FY | 2.1 Billion INR | 36.07% |
| 2018 Q4 | 753.4 Million INR | 46.66% |
| 2018 Q2 | 440.1 Million INR | 11.02% |
| 2018 Q1 | 396.4 Million INR | -22.49% |
| 2017 Q2 | 483.9 Million INR | 271.94% |
| 2017 Q3 | 420 Million INR | -13.21% |
| 2017 Q4 | 511.4 Million INR | 21.76% |
| 2017 FY | 1.54 Billion INR | 6.28% |
| 2017 Q1 | 130.1 Million INR | -69.6% |
| 2016 FY | 1.45 Billion INR | -15.01% |
| 2016 Q4 | 428 Million INR | 31.77% |
| 2016 Q1 | 302.7 Million INR | 4.52% |
| 2016 Q2 | 383 Million INR | 26.53% |
| 2016 Q3 | 324.8 Million INR | -15.2% |
| 2015 Q4 | 289.6 Million INR | -35.3% |
| 2015 Q2 | 277.3 Million INR | -30.71% |
| 2015 Q1 | 400.2 Million INR | 3.66% |
| 2015 FY | 1.71 Billion INR | 42.82% |
| 2015 Q3 | 447.6 Million INR | 61.41% |
| 2014 FY | 1.19 Billion INR | 9.64% |
| 2014 Q4 | 386.05 Million INR | 60.63% |
| 2014 Q3 | 240.33 Million INR | -27.95% |
| 2014 Q2 | 333.55 Million INR | 40.06% |
| 2014 Q1 | 238.14 Million INR | 5.44% |
| 2013 Q2 | 422.77 Million INR | 44.53% |
| 2013 FY | 1.09 Billion INR | 8.95% |
| 2013 Q4 | 225.85 Million INR | 49.02% |
| 2013 Q3 | 151.55 Million INR | -64.15% |
| 2013 Q1 | 292.52 Million INR | 57.47% |
| 2012 Q3 | 164.1 Million INR | -38.3% |
| 2012 Q4 | 185.76 Million INR | 13.19% |
| 2012 FY | 1 Billion INR | 76.7% |
| 2012 Q2 | 265.99 Million INR | -31.28% |
| 2012 Q1 | 387.07 Million INR | 23.87% |
| 2011 Q3 | 167.2 Million INR | 0.0% |
| 2011 FY | 567.58 Million INR | -29.06% |
| 2011 Q4 | 312.47 Million INR | 86.88% |
| 2010 FY | 800.12 Million INR | -31.95% |
| 2009 FY | 1.17 Billion INR | -19.57% |
| 2008 FY | 1.46 Billion INR | 22.12% |
| 2007 FY | 1.19 Billion INR | 30.53% |
| 2006 FY | 917.08 Million INR | 80.37% |
| 2005 FY | 508.44 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 2.76 Million INR | 55617.366% |
| Biocon Limited | 10.22 Billion INR | 115.007% |
| Blue Jet Healthcare Limited | 1.63 Billion INR | 193.709% |
| Concord Biotech Limited | 3.08 Billion INR | 149.805% |
| FERMENTA BIOTECH LIMITED | -230.59 Million INR | -565.444% |
| GENOMIC VALLEY BIOTECH LIMITED | 151.81 Thousand INR | 1010849.713% |
| Lyka Labs Limited | -24.89 Million INR | -6064.136% |
| Panacea Biotec Limited | -11.73 Million INR | -12981.841% |
| SAMSRITA LABS LIMITED | -2.62 Million INR | -58413.985% |
| Servoteach Industries Limited | -2.37 Million INR | -64537.742% |
| SMS Lifesciences India Limited | 90.92 Million INR | 1787.599% |
| Supriya Lifescience Limited | 1.19 Billion INR | 228.826% |
| Syngene International Limited | 5.1 Billion INR | 130.088% |
| TAKE Solutions Limited | -1.19 Billion INR | -28.281% |
| Titan Biotech Limited | 248.53 Million INR | 717.43% |
| Transgene Biotek Limited | -6.55 Million INR | -23309.611% |
| Vanta Bioscience Limited | -23.15 Million INR | -6525.934% |